S&P 500 Consumer Staples Sector SEC Filings — June 09, 2026

09-06-2026

Nathan's Famous, Inc. reported fiscal 2026 revenue growth of 9.4% to $162.1M, driven by a 15.2% increase in Branded Product Program sales to $105.8M. However, net income declined 16.7% to $20.0M ($4.85 per diluted share) from $24.0M ($5.87 per diluted share) in fiscal 2025, primarily due to a 19% increase in beef costs that compressed margins. The Board declared a quarterly cash dividend of $0.50 per share, and the pending acquisition by Smithfield Foods for $102.00 per share (total enterprise value ~$450M) is now expected to close in the second half of 2026.

• · License royalties were flat at $37.4M in fiscal 2026 vs fiscal 2025, reflecting stability in the licensing business and steady income from the Smithfield Foods agreement.
• · Branded Product Program income from operations fell 40.0% to $4.3M despite a 15.2% sales increase, due to a 19% rise in beef costs.
• · Company-owned restaurant sales declined 1.6% to $12.5M, impacted by lower foot traffic from unfavorable weather at Coney Island locations during the key summer season.
• · Franchise operations revenues increased 4.1% to $4.3M, with franchise restaurant sales up 4.8% to $70.1M; 23 franchised locations opened and 32 closed during fiscal 2026.
• · Advertising revenue was essentially flat at $2.1M.
• · The Board declared a quarterly cash dividend of $0.50 per share, payable June 30, 2026 to shareholders of record June 22, 2026.
• · The pending acquisition by Smithfield Foods for $102.00 per share (total enterprise value ~$450M) is now expected to close in the second half of 2026, delayed from prior timeline due to CFIUS review delays from the partial government shutdown.
• · Corporate expenses increased significantly to $14.0M in fiscal 2026 from $10.3M in fiscal 2025, driven by transaction costs related to the Merger Agreement.

09-06-2026

AITX filed its 10-K for the fiscal year ended February 28, 2026, reporting a 26% increase in revenue to $7.7M, driven by a 37% surge in device rental activities to $6.9M. However, direct sales of goods and services declined 24% to $825K, and the company continued to operate at a net loss of $14.5M, though this was a 23% improvement from the prior year's $18.9M loss. The company also engaged in extensive debt-for-equity exchanges and share issuances, with outstanding shares rising from 9.2B to 14.4B over the two-year period, and then dropping sharply to 267.9M by February 28, 2026, reflecting a reverse stock split or similar restructuring.

• · The company's authorized dealer network has grown to over 100 dealers across the United States, Canada, and the European Union.
• · Enterprise and Fortune 500 end users serve as both a revenue base and credibility base for SARA adoption.
• · Shares outstanding dropped dramatically from 14,412,453,768 on Feb 28, 2025 to 267,872,804 on Feb 28, 2026, indicating a likely reverse stock split.
• · During the period March 1, 2025 to February 28, 2026, the company issued 50,403,802 shares through other registered sales.
• · The company recorded a loss on disposal of fixed assets of $22,312 in FY 2026, compared to $0 in the prior year.
• · Operating lease cost and rent increased 5% YoY to $251,883.

09-06-2026

Verde Clean Fuels, Inc. announced on June 9, 2026, the resignation of director Martijn Dekker, effective June 3, 2026. The departure is a routine board change and no reasons or immediate replacements were disclosed.

• · The resignation was effective immediately on June 3, 2026.
• · Item 5.02(b) disclosure relates to director departure; no election of a replacement director was announced.

09-06-2026

J M Smucker Co reported net sales of $9,050.9M for fiscal year 2026, up 4% from $8,726.1M in 2025, driven by strong growth in U.S. Retail Coffee (+18%) and Away From Home (+15%). However, gross profit declined 10% to $3,034.5M, and the company reported a net loss of $138.7M (improved from a $1,230.8M loss in 2025), while adjusted earnings per share fell 10% to $9.15. Segment performance was mixed, with Sweet Baked Snacks sales dropping 18% and segment profit plunging 56%.

• · Net sales excluding divestitures and foreign currency exchange rose 5% to $9,047.6M.
• · Gross profit margin contracted to 33.5% from 38.8%.
• · Goodwill impairment charges were 5.6% of net sales in 2026 vs. 19.0% in 2025.
• · Other intangible assets impairment charges were 5.0% of net sales in 2026 vs. 3.7% in 2025.
• · Segment profit margins: U.S. Retail Coffee fell to 21.2% from 28.3%; Sweet Baked Snacks dropped to 10.0% from 18.6%.
• · Net cash used for investing activities was $258.8M in 2026 vs. $100.3M in 2025.
• · Net cash used for financing activities was $1,226.5M in 2026 vs. $1,102.7M in 2025.
• · Capital expenditures were $317.4M in 2026 vs. $393.8M in 2025.
• · Total capital (debt plus equity) decreased to $12,507.5M from $13,760.2M.
• · Projected principal payments for FY 2027 are $150.0M; dividend payments $469.3M; capital expenditures $325.0M; interest payments $343.2M.
• · Long-term debt obligations total $6,603.2M, with $150.0M due in 2027, $1,250.0M in 2028-2029, $500.0M in 2030-2031, and $4,703.2M in 2032 and beyond.
• · Total contractual obligations (debt, interest, purchase obligations) amount to $13,824.4M.

09-06-2026

This is a DEFA14A filing by Haemonetics Corporation, submitted on June 9, 2026, as definitive additional proxy soliciting materials. The filing indicates no fee is required and does not contain any financial results, operational metrics, or period-over-period comparisons.

• · Filing type is DEFA14A (Definitive Additional Proxy Materials).
• · Filing date is June 9, 2026.
• · No fee was required for this filing.
• · The filing is submitted by the registrant (Haemonetics Corporation).

09-06-2026

Lakeland Industries reported a net income of $0.4M for Q1 FY26, a significant turnaround from a net loss of $3.9M in the prior-year quarter, driven by a $6.5M gain on asset sales. However, gross profit declined 4.9% to $14.9M, and operating expenses remained high at $19.1M, partially offsetting the improvement.

• · Net sales increased only 1.4% YoY to $47.4M, indicating flat top-line growth.
• · Gross profit margin declined to 31.4% in Q1 FY26 from 33.5% in Q1 FY25.
• · Operating expenses decreased 6.0% YoY to $19.1M, but still exceeded gross profit.
• · The company recorded a $6.5M gain on sale of certain assets, which was the primary driver of operating profitability.
• · Cash provided by operating activities was $5.8M in Q1 FY26 vs. cash used of $4.8M in Q1 FY25.
• · Total debt (current portion of loans payable + long-term debt) decreased to $27.2M at April 30, 2026 from $32.3M at January 31, 2026.
• · The company completed a business acquisition with total net assets acquired of $4.1M, including $2.6M in customer relationships and $1.0M in goodwill.
• · Deferred revenue of $6.6M was recorded at April 30, 2026, compared to zero at January 31, 2026.
• · No dividends were paid in Q1 FY26, compared to $0.3M in Q1 FY25.

09-06-2026

Blue Biofuels, Inc. (BIOF) disclosed on June 8, 2026, that its independent auditor, Assure CPA, LLC, resigned after merging into Sadler, Gibb & Associates, LLC. The Audit Committee simultaneously approved the engagement of Sadler Gibb as the new independent registered public accounting firm for fiscal year 2026. No disagreements or reportable events occurred with Assure CPA during the past two fiscal years, though its audit reports included a going concern qualification for both 2024 and 2025.

• · Assure CPA's audit reports for fiscal years 2024 and 2025 contained an explanatory paragraph expressing substantial doubt about the Company's ability to continue as a going concern.
• · No disagreements or reportable events occurred with Assure CPA during fiscal years 2024 and 2025 and the subsequent interim period through June 3, 2026.
• · The Company did not consult with Sadler Gibb on any accounting, auditing, or financial reporting matters prior to engagement.
• · The resignation and engagement were approved by the Audit Committee on June 8, 2026.

09-06-2026

Dell Technologies reported a strong Q1 FY27 with total net revenue of $43,842M, up 87.5% YoY from $23,378M, driven by a surge in product revenue to $38,105M (up 116.5% YoY). Net income rose to $3,438M from $965M, and diluted EPS increased to $5.24 from $1.37. However, services revenue declined slightly to $5,737M from $5,779M (-0.7% YoY), and the company's stockholders' equity remained negative at ($1,404M), though improved from ($2,470M) at year-end. Operating cash flow was $4,081M, up from $2,796M, but investing cash flow turned more negative at ($1,067M) vs. ($88M) due to higher capex.

• · Gross margin increased to $7,782M from $4,937M YoY, with gross margin percentage rising to 17.7% from 21.1% (decline in margin rate).
• · Operating expenses rose to $4,126M from $3,772M YoY (+9.4%), driven by higher SG&A ($3,143M vs. $2,964M) and R&D ($983M vs. $808M).
• · Interest and other income was $292M vs. an expense of ($82M) in the prior year.
• · Income tax expense increased to $510M from $118M, reflecting higher pre-tax income.
• · Accounts receivable surged to $25,854M from $17,585M at year-end, a 47% increase, contributing to negative working capital changes.
• · Inventories rose to $15,052M from $10,437M (+44.2%), and accounts payable increased to $45,261M from $33,630M (+34.6%).
• · Debt repayments ($2,788M) slightly exceeded proceeds from debt ($2,465M), resulting in net debt reduction of $323M.
• · Share repurchases totaled $1,616M (treasury stock) plus $537M for employee tax withholdings, totaling $2,153M in the quarter.
• · Dividends declared increased to $0.630 per share from $0.525 per share YoY (+20%).
• · Total assets grew to $114,913M from $101,286M (+13.5%), while total liabilities increased to $116,317M from $103,756M (+12.1%).

09-06-2026

Stifel Financial Corp. filed an 8-K on June 9, 2026, announcing an amendment to its Second Restated Certificate of Incorporation to increase authorized common shares from 200 million to 291 million and authorized preferred shares from 1 million to 3 million. The amendment was approved by the board and shareholders, and executed by Chairman and CEO Ronald J. Kruszewski.

• · The amendment increases authorized common stock from 200 million to 291 million shares and preferred stock from 1 million to 3 million shares.
• · The amendment was adopted under Section 242 of the Delaware General Corporation Law.
• · The filing includes items 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws), 5.07 (Submission of Matters to a Vote of Security Holders), and 9.01 (Financial Statements and Exhibits).

09-06-2026

The Hershey Company appointed Joe Park to its Board of Directors, effective June 29, 2026. Mr. Park brings over 20 years of experience in digital transformation and technology strategy from roles at State Farm, Yum! Brands, and Walmart. He will serve on the Audit and Finance and Risk Management Committees and qualifies as an independent director under NYSE standards.

• · Mr. Park currently serves as Executive Vice President and Chief Digital and Information Officer at State Farm, responsible for technology, data, and innovation functions.
• · Prior roles include Chief Digital and Technology Officer at Yum! Brands, President of Byte by Yum! (an AI-driven restaurant technology platform), and Chief Digital and Technology Officer for Pizza Hut Global.
• · Mr. Park will be compensated under the Company's non-employee director compensation program as described in the 2026 proxy statement filed March 25, 2026.
• · No arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K exist in connection with his appointment.

09-06-2026

Hubbell Incorporated completed the acquisition of NSI Industries on June 9, 2026, for $3.0 billion in cash, funded through a combination of a $900 million term loan, $1.9 billion in senior notes, and commercial paper. NSI Industries is a provider of electrical fittings, connectors, components, and wire management products serving industrial, infrastructure, and commercial markets.

• · The acquisition was completed on June 9, 2026, following the previously disclosed Stock Purchase Agreement dated May 1, 2026.
• · The purchase price is subject to customary adjustments related to cash, indebtedness, working capital, and transaction expenses.
• · The term loan facility was previously disclosed in an 8-K filed on May 15, 2026.
• · The senior notes issuance was previously disclosed in an 8-K filed on June 8, 2026.

09-06-2026

Pebblebrook Hotel Trust announced it will report Q2 2026 financial results on July 29, 2026 after market close, with a conference call on July 30, 2026 at 9:00 AM ET. The company owns 43 hotels with approximately 10,900 guest rooms across 13 urban and resort markets. No financial figures or period-over-period comparisons were provided in this filing.

• · Q2 2026 earnings release date: July 29, 2026 after market close
• · Conference call: July 30, 2026 at 9:00 AM ET
• · Dial-in: +1 (877) 407-3982
• · Webcast available at www.pebblebrookhotels.com
• · Company is the largest owner of urban and resort lifestyle hotels in the U.S.

09-06-2026

Cloudflare, Inc. filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 30, 2026. The filing includes proposals to elect three Class I directors, ratify the appointment of the independent registered public accounting firm, conduct an advisory vote on executive compensation, adopt an amended and restated certificate of incorporation, amend and restate the 2019 Plan and ESPP, and approve adjournments. The record date is June 5, 2026.

• · The Annual Meeting will be held virtually on June 30, 2026 at 8:30 AM Pacific Time.
• · Stockholders of record as of June 5, 2026 are entitled to vote.
• · Proposals include election of directors, ratification of auditor, advisory vote on compensation, charter amendment, 2019 Plan and ESPP amendments, and adjournment approval.

09-06-2026

Cracker Barrel reported Q3 FY2026 revenue of $797.4M, down 2.9% YoY, with GAAP EPS of $1.90 (boosted by a $47.4M litigation settlement) but adjusted EPS of only $0.29, down 50% from $0.58 a year ago. Adjusted EBITDA fell 16.2% to $40.3M from $48.1M, though the company raised its full-year revenue guidance to $3.27B-$3.30B and adjusted EBITDA guidance to $120M-$125M (from $85M-$100M). Comparable store restaurant sales declined 2.6% and retail sales fell 1.8%, while operating income plunged 55% to $6.7M.

• · GAAP net income of $42.8M includes a $47.4M benefit from interchange fee litigation settlement; without it, adjusted net income was only $6.5M.
• · Total debt of $486.6M consists of $149.9M short-term (0.625% Convertible Notes due June 2026) and $336.8M long-term (1.75% Convertible Notes due 2030); no borrowings on credit facility.
• · Company intends to repay the $149.9M short-term debt by drawing on its $541.3M available credit facility.
• · Board declared a quarterly dividend of $0.25 per share, payable August 12, 2026 to holders of record July 17, 2026.
• · FY2026 guidance raised: revenue $3.27B-$3.30B (from $3.24B-$3.27B), adjusted EBITDA $120M-$125M (from $85M-$100M).
• · Commodity inflation guidance lowered to low 2% range (from 2.0%-2.5%); hourly wage inflation guidance lowered to low 2% range (from 2.5%-3.0%).
• · Capital expenditures unchanged at $105M-$115M; 2 new stores opened (no change).
• · Nine-month FY2026 total revenue declined 6% YoY to $2.469B; GAAP net income fell 51% to $19.5M; operating loss of $25.6M vs. income of $51.1M in prior year period.

09-06-2026

Relay Therapeutics, Inc. filed a Certificate of Second Amendment to its Fourth Amended and Restated Certificate of Incorporation, increasing the authorized common stock from an unspecified prior amount to 450,000,000 shares and authorized preferred stock to 10,000,000 shares, for a total of 460,000,000 authorized shares. The amendment was approved by the Board of Directors and stockholders, and was executed on June 9, 2026. No financial results or period-over-period comparisons are included in this filing.

• · The amendment replaces the first paragraph of Article IV of the Fourth Amended and Restated Certificate of Incorporation.
• · The corporation was originally incorporated on May 4, 2015 under the name Allostery, Inc.
• · The amendment was approved by stockholders in accordance with Section 228 of the General Corporation Law of Delaware.
• · The amendment was adopted in accordance with Section 242 of the General Corporation Law.

09-06-2026

Simon Property Group L.P. announced that its indirect subsidiary, Simon Global Development B.V., priced an offering of €500,000,000 aggregate principal amount of 3.650% guaranteed notes due 2031. The notes are unsecured and fully and unconditionally guaranteed by the Company, with the offering scheduled to close on June 15, 2026. The offering is limited to non-U.S. persons outside the United States under Regulation S and has not been registered under the Securities Act.

• · The notes will be unsecured and fully and unconditionally guaranteed by Simon Property Group L.P.
• · The offering is scheduled to close on June 15, 2026, subject to customary closing conditions.
• · The notes are being offered to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act of 1933.
• · The notes have not been and will not be registered under the Securities Act or applicable state or other securities laws.

09-06-2026

ClearSign Technologies Corporation held its 2026 annual meeting on June 8, 2026, with 67.79% of voting power represented, and all four director nominees were re-elected. Stockholders also approved, on an advisory basis, the appointment of BPM CPA LLP as independent auditor, the amended and restated 2021 Equity Incentive Plan, executive compensation, and an adjournment proposal. Notably, while all proposals passed, significant opposition was seen: against votes for directors ranged from 217,011 to 418,786, and Proposal 3 (A&R 2021 Plan) faced 29.8% against votes among shares voted.

• · Against votes for director Anthony DiGiandomenico were the highest at 418,786, representing 19.1% of shares voted (excluding broker non-votes).
• · Proposal 3 (A&R 2021 Plan) had the highest percentage of against votes among voted shares at 29.8% (excluding broker non-votes).
• · Broker non-votes totaled 1,453,588 on all director elections and Proposals 3, 4, and 5, indicating a significant portion of shares were held by brokers without voting instructions.
• · Quorum was established with 3,666,852 shares (67.79% of voting power) present or represented by proxy.

09-06-2026

MoonLake Immunotherapeutics held its 2026 Annual General Meeting on June 4, 2026, where shareholders approved all proposals, including the election of Class I director Spike Loy, ratification of Baker Tilly US, LLP as independent auditor, an advisory vote on executive compensation, and an amendment to the 2022 Equity Incentive Plan. The plan amendment increases the share reserve by 5,000,000 Class A ordinary shares, removes liberal share recycling, imposes a one-year minimum vesting requirement, and extends the plan term to June 4, 2036. All proposals received strong shareholder support, with the advisory vote on executive compensation receiving 50,365,168 votes for and only 731,158 against, indicating broad approval of the company's compensation practices.

• · The amended plan extends the term to June 4, 2036, and incorporates a one-year minimum vesting requirement for all awards.
• · The plan amendment removes liberal share recycling provisions and revises non-employee director compensation limits.
• · All proposals passed with strong majorities; the lowest support was for the advisory executive compensation vote (approximately 98.6% of votes cast in favor).
• · The company is incorporated in the Cayman Islands and its Class A ordinary shares trade on the Nasdaq Capital Market under ticker MLTX.

09-06-2026

Brookfield Asset Management Ltd. filed an 8-K on June 9, 2026, announcing the issuance of a press release (Exhibit 99.1) regarding other events. The filing does not disclose the specific content of the press release, but it was incorporated by reference. No financial figures or performance metrics were provided in this filing.

• · The press release was issued on June 9, 2026, and is attached as Exhibit 99.1.
• · The filing is under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits).
• · No financial statements or quantitative data were included in this 8-K.

09-06-2026

FingerMotion, Inc. (FNGR) announced a non-binding MOU with BlueFlare Energy Solutions to jointly develop a distributed network of micro-scale edge AI inference compute sites across Western Canada, with the first project (PR1) in Alberta. The collaboration leverages BlueFlare's proprietary BALA™ load-balancing technology and behind-the-meter natural gas to power both AI inference and bitcoin mining. However, the MOU and anticipated LOI are non-binding, and there is no assurance that any definitive agreement will be reached or that the PR1 Project or broader network build-out will be completed.

• · The MOU establishes BlueFlare as FingerMotion's exclusive partner in Alberta, British Columbia, and Saskatchewan for co-located AI inference and bitcoin mining sites.
• · Each micro-scale edge AI inference compute site is expected to be in the 0.5 MW to 2 MW range.
• · The PR1 site includes a 1.0 MW air-cooled Bitcoin mining container (manufactured by TNDS) and 120 active Bitmain Antminer S21 Pro 234T ASICs (126 delivered with 5% DOA buffer), representing 28.08 PH/s aggregate hashrate.
• · BlueFlare retains ownership of on-site natural gas generation equipment; FingerMotion would not acquire it.
• · Host-operated services are at a fixed all-in rate of US$0.03 per kWh for an initial three-year term, with 3% annual escalation thereafter.
• · Additional initial project sites (two) are under evaluation but are expected to be advanced under a separate Commercial Term Sheet.
• · The MOU and LOI are non-binding; closing is subject to due diligence, definitive agreements, regulatory approvals, and other conditions.
• · No financial terms (e.g., investment amounts, revenue projections) were disclosed.

09-06-2026

NexGel, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders to be held on July 10, 2026. The meeting includes seven proposals: election of seven directors, approval of Nasdaq 20% issuance for shares from April/May 2026 private placements, reincorporation from Delaware to Nevada, a fallback increase in authorized shares from 25M to 100M, a fallback discretionary reverse stock split (1:2 to 1:10), an advisory vote on executive compensation, and ratification of auditors. The Board recommends a 'FOR' vote on all proposals.

• · Record date for voting is June 3, 2026.
• · Proposal 2 covers shares from April 2026 and May 2026 private placements, including anti-dilution adjustments and conversion price reset features.
• · Proposal 3 (reincorporation to Nevada) includes bundled provisions for 100M authorized shares and discretionary reverse stock split; if approved, Proposals 4 and 5 become moot.
• · Proposal 5 reverse stock split ratio range is 1-for-2 to 1-for-10, at Board discretion within one year of approval.
• · Proposal 7 seeks ratification of Turner, Stone & Company, L.L.P. as auditor for fiscal year ending December 31, 2026.
• · Proxy materials are available at www.proxyvote.com and were mailed on or about June 9, 2026.

09-06-2026

US Elemental CEO Ian Rodger discussed with Fastmarkets that lithium demand growth (~20% YoY for decades) is outpacing US supply chain development. While government support is expected to increase, current lithium prices may not be attractive enough for long-term investment, and China's dominance with lower prices ($19.50–20.50/kg in China vs. $20.50–24.00/kg in the US) poses a threat to an independent US supply chain. The company is positioned to be a large domestic supplier, though supply chain growth may be too late to meet rising demand.

• · Lithium demand growth is closely tied to EVs and the AI boom, though US EV demand faced headwinds from the rescission of the EV tax credit under the One Big Beautiful Bill Act in July 2025.
• · Buyers are currently unwilling to pay a premium for non-Chinese lithium, and all material flows through China, offsetting tariff impacts.
• · The pathway to decoupling from China is building a vertically integrated US supply chain, though adding capacity outside of China remains difficult.
• · US Elemental is one of the largest lithium projects in the US and expects to supply over the long term.

09-06-2026

The Gabelli Dividend & Income Trust (GDV) posted a microsite urging shareholders to vote the WHITE proxy card FOR its three board nominees (Frank J. Fahrenkopf Jr., Colin J. Kilrain, Salvatore J. Zizza) at the 2026 annual meeting, rejecting a competing gold card from activist hedge fund Saba Capital. The Fund highlights a nearly 23% investor return in the 12 months ended May 5, 2026, and a 6.1% current return with an annual distribution raised to $1.80 per share. However, the election is contested, and the board warns that not voting or voting on Saba's gold card could help Saba gain leverage, potentially threatening the Fund's long-term income strategy.

• · The deadline to vote is June 28, 2026 at 11:59 PM ET.
• · Shareholders who already voted the gold card can revoke by contacting Alliance Advisors at 1-866-206-7868.
• · GDV's board has 10 of 13 members independent; four new independent trustees added since 2021.
• · Saba Capital has been actively selling its GDV shares while simultaneously seeking a board seat.
• · Saba's historical agenda includes pushing funds toward open-end conversion or liquidation.
• · The Fund's definitive proxy statement was filed with the SEC on March 31, 2026.

09-06-2026

On June 8, 2026, Teleflex Incorporated's independent board members approved a special restricted stock unit award of $600,000 to Stuart A. Randle, recognizing his extended service as Interim President and CEO, including contributions to operations, governance, investor relations, and the CEO search. The award vests on the earlier of June 8, 2027, or the 2027 annual meeting.

• · The award was recommended by the Compensation Committee of the Board.
• · The award acknowledges Mr. Randle's service for a longer period than initially expected.
• · Grant date is June 8, 2026; vesting occurs on the earlier of June 8, 2027, or the date of the 2027 annual meeting of stockholders.

09-06-2026

Allegiant Travel Company (ALGT) filed an 8-K on June 9, 2026 disclosing pro forma financial information for its pending acquisition of Sun Country Airlines, along with recent aircraft financings and a new $500M senior secured notes offering due 2031. The company also launched a cash tender offer for up to all of its $403M outstanding 7.25% senior secured notes due 2027. Post-March 31, 2026, Allegiant completed $224.6M in borrowings across three new aircraft financing facilities, including a $115M facility at variable SOFR-based rates.

• · The pro forma financial information covers the three months ended March 31, 2026 and the year ended December 31, 2025.
• · The new $500M notes are being offered to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S.
• · The tender offer is for up to all outstanding $403M of 7.25% notes due 2027, representing a potential refinancing of higher-cost debt.
• · All three new aircraft financing facilities bear interest at variable rates based on three-month SOFR, with terms ranging from 3 to 12 years.
• · The predelivery deposit financing facility is now fully drawn after the final $25.1M drawdown.

09-06-2026

On June 3-5, 2026, the Federal Home Loan Bank of Chicago issued consolidated obligation bonds totaling $270 million across seven tranches, with maturities ranging from 2028 to 2032 and coupon rates between 4.18% and 4.85% (plus one variable-rate floater). The obligations are joint and several among the eleven Federal Home Loan Banks, are not guaranteed by the U.S. government, and are reported under Item 2.03 of Form 8-K. No prior-period comparison is available as this is a single-event filing.

• · The largest single issuance was a $175 million variable-rate Single Index Floater with a maturity of only six months (December 11, 2026).
• · All fixed-rate bonds are callable (Optional Principal Redemption) with call styles including European, American, and Bermudan.
• · The longest maturity is June 25, 2032 (4.85% coupon, $25 million).
• · Consolidated obligations are joint and several obligations of all eleven Federal Home Loan Banks and are not guaranteed by the U.S. government.
• · Discount notes with maturity of one year or less issued in the ordinary course of business are excluded from this filing.

09-06-2026

Edgemode, Inc. entered into a securities purchase agreement with an accredited investor on June 3, 2026, issuing a convertible promissory note with a principal amount of $300,000, an original issuance discount of $50,000, and net proceeds of $250,000 for working capital. The note matures on August 3, 2026, and carries a 12% annual interest rate with a conversion price of $0.01 per share, subject to potential resets to lower prices if the stock trades below certain thresholds. The note includes standard events of default, a 9.99% ownership limitation, and restrictions on senior borrowings.

• · The note matures on August 3, 2026, indicating a very short-term maturity of about two months.
• · Conversion price is $0.01 per share initially, with potential resets to $0.0075 per share or lower if stock price declines.
• · The note was issued in a private placement relying on Section 4(a)(2) exemption from registration.
• · The company received only $250,000 in net proceeds after a $50,000 discount, implying immediate effective interest cost of 20% at issuance.
• · The filing does not disclose the name of the accredited investor.

09-06-2026

Axiom Intelligence Acquisition Corp 1 (SPAC) filed a Form 8-K on June 9, 2026, disclosing that it entered into a Business Combination Agreement on May 25, 2026, with Terra Quantum AG, a Swiss quantum technology company. The filing includes an investor deck presentation and forward-looking statements regarding the proposed merger, which is subject to shareholder and regulatory approvals. No financial figures or performance metrics were provided in this filing.

• · The Business Combination Agreement was entered into on May 25, 2026.
• · The SPAC is incorporated in the Cayman Islands and its securities trade on Nasdaq under symbols AXINU (Units), AXIN (Class A ordinary shares), and AXINR (Rights).
• · The combined company (PubCo) will be organized under the laws of Switzerland.
• · The filing includes a forward-looking statements section with extensive risk factors related to the quantum technology industry, including market adoption, technological feasibility, and competition.
• · No financial data, redemption amounts, or trust account balances were disclosed in this filing.

09-06-2026

American Well Corporation filed a DEFA14A supplement to its 2026 proxy statement, announcing that Dr. Roy Schoenberg will not stand for re-election as a Class III director at the upcoming Annual Meeting. The Board has decided not to nominate a substitute candidate, and votes on his re-election will not be counted. This update does not affect previously submitted proxies unless stockholders wish to change their votes.

• · The supplement amends the definitive proxy statement filed on April 23, 2026.
• · Stockholders who already submitted proxies do not need to resubmit unless they wish to change their vote.
• · The Board will not nominate a substitute nominee for the Class III director seat.

09-06-2026

Federal Home Loan Bank of Des Moines issued a schedule of 10 callable consolidated obligation bonds with a total par value of $265 million, settled between June 3 and June 5, 2026. The bonds have maturities ranging from 2028 to 2046, with fixed and variable rate types, and various call styles (Bermudan, American, European). The largest single issuance was a $75 million fixed-rate Bermudan bond (4.13% coupon), while a $60 million variable-rate Bermudan floater (N/A coupon) was also included.

• · All bonds are callable with Optional Principal Redemption provisions.
• · Call styles include Bermudan (7 bonds), American (2 bonds), and European (1 bond).
• · Rate types: 9 fixed-rate constant bonds and 1 variable-rate single index floater.
• · The variable-rate floater (CUSIP 3130BAZJ9) has no coupon rate listed (N/A) and matures in 2028.
• · The shortest maturity is 2027 (bond with 4.13% coupon, $75M par), the longest is 2046 (bond with 5.81% coupon, $10M par).
• · Coupon rates range from 4.13% to 5.81% for fixed-rate bonds.

09-06-2026

Limoneira reported Q2 FY2026 revenue of $23.9M, exceeding expectations, but net loss widened to $21.4M from $3.5M a year ago due to $9.3M impairment and $7.8M loss on asset disposals. The company increased full-year avocado volume guidance to 5.5-6.5M pounds, executed a $16M partial sale of Paso Robles vineyard, and formed an Agromin joint venture. However, operating loss surged to $21.7M from $3.3M, and adjusted EBITDA loss deepened to $1.7M from $0.2M, reflecting the strategic transition to Sunkist and exit from non-core operations.

• · Fresh lemon carton volume fell 24.2% YoY to 1,028,000 cartons, but average price rose 14.5% to $16.63 per carton.
• · Avocado revenue was nominal in Q2 FY2026 vs $2.8M in Q2 FY2025 due to harvest timing; 1,232,000 pounds sold at $2.26/lb in prior year.
• · Orange revenue nominal vs $1.6M; specialty citrus and wine grape revenue nominal vs $0.7M; farm management revenue zero vs $0.3M.
• · Total costs and expenses rose 18.4% to $45.6M, driven by $9.3M impairment and $7.8M loss on asset disposals.
• · Adjusted net loss for diluted EPS was $5.2M ($0.29/share) vs $3.1M ($0.17/share) a year ago.
• · H1 FY2026 net cash used in operating activities was $16.1M, up 302.5% from $4.0M in H1 FY2025.
• · Long-term debt increased 29.2% to $93.7M from $72.5M at FY2025 year-end.
• · Harvest at Limoneira JV had $19.3M in cash and equivalents as of April 30, 2026.
• · Agromin JV expected operational in H2 FY2027; annual lease payment of $560,000.
• · Windfall Farms sale of 80% interest for $16M ($10M cash + $6M note) expected to close in Q4 FY2026.
• · Company ceased citrus farming on 600 acres in Yuma, Arizona to focus on water monetization.
• · Full-year FY2026 fresh lemon volume guidance unchanged at 4.0M-4.5M cartons.
• · Avocado volume guidance raised to 5.5M-6.5M pounds from prior 5.0M-6.0M pounds.
• · Company expects positive adjusted EBITDA in Q3 and Q4 FY2026.
• · Targeted $10M in annual SG&A savings, excluding Q2 allowance on foreign receivables.

09-06-2026

Cyclerion Therapeutics, Inc. has filed an S-4/A registration statement with the SEC on June 9, 2026, relating to its proposed merger with Korsana Biosciences Inc. The transaction is expected to render Cyclerion a shell company, subjecting the combined entity to stringent SEC requirements including a 12-month S-3 ineligibility, a 60-day S-8 filing delay, three-year 'ineligible issuer' status, and one-year Rule 144 resale restrictions for affiliates and restricted security holders. These restrictions will increase the combined company's cost of capital, limit equity plan flexibility, and impose burdensome resale limitations on shares received by Korsana affiliates in the merger.

• · Post-merger, the Combined Company will be subject to a 12-month calendar bar from using Form S-3 for capital raising.
• · The Combined Company will have to wait at least 60 calendar days after closing before filing a Form S-8 for equity plans or awards.
• · The Combined Company will be deemed an 'ineligible issuer' for three years after closing, precluding incorporation by reference in Form S-1 filings, use of free writing prospectuses, and well-known seasoned issuer status.
• · Holders of Rule 145(c) securities (Korsana affiliates receiving Combined Company shares) will be treated as underwriters for resale purposes unless sold in a fixed price offering with named underwriting.
• · Rule 144(i)(2) will restrict public resale of Rule 145(c) securities and other 'restricted' or 'control' securities for one year after the Form 10 information is filed with the SEC.

09-06-2026

Socket Mobile, Inc. held its 2026 Annual Meeting on June 3, 2026, where all five director nominees were elected, executive compensation was approved on an advisory basis with 81.0% support, and the appointment of Sadler, Gibb & Associates LLC as independent auditors was ratified with 99.7% approval. However, director Kevin J. Mills received more votes withheld (2,335,484) than votes for (2,170,495), indicating significant shareholder dissent, while the overall voter turnout was 70.96% of outstanding shares.

• · Director Kevin J. Mills received 2,170,495 votes for and 2,335,484 votes withheld, failing to secure a majority of votes cast.
• · The record date for the meeting was April 6, 2026, with 8,222,958 common shares and 733,194 restricted shares outstanding.
• · A quorum of 6,352,157 shares (70.96% of total shares) was established.
• · Item 3 (auditor ratification) passed with 6,330,489 votes for, 14,095 against, and 7,573 abstained.

09-06-2026

BriaCell Therapeutics Corp. reported a net loss of $7.2M for the three months ended April 30, 2026, up from a $6.2M loss in the same period last year, driven by increased R&D spending. For the nine-month period, net loss widened to $22.8M from $18.4M in the prior year. The company completed a public offering in January 2026 generating approximately $30M in gross proceeds, and its cash and short-term investments totaled $22.8M as of April 30, 2026, compared to $17.9M as of July 31, 2025. However, the company has an accumulated deficit of $134.3M and negative operating cash flows of $22.7M year-to-date, casting substantial doubt on its ability to continue as a going concern.

• · BriaCell completed a public offering in January 2026 generating approximately $30 million in gross proceeds.
• · The company's short-term investments increased to $15.9M as of April 30, 2026, from $7.4M as of July 31, 2025.
• · Trade payables decreased by 33.4% to $2.2M from $3.3M, while accrued expenses more than doubled to $1.4M from $0.7M.
• · The warrant liability decreased significantly from $337,672 to $71,854.
• · BriaCell's equity investment in BC Therapeutics increased to $750,982 from $524,278 due to additional investments of $260,000 in the nine-month period.
• · Cash used in operating activities was $22.7M for the nine months ended April 30, 2026, compared to $20.0M in the prior year period.
• · Financing activities provided $27.9M in net proceeds from share issuance, compared to $31.9M in the prior year period.
• · As of April 30, 2026, BriaCell owned approximately 78% of BriaPro following the sCD80 license transaction that closed on March 31, 2026.
• · Net loss per share basic and diluted improved to $(5.73) for the nine-month period from $(67.08) in the prior year, primarily due to a significant increase in weighted average shares outstanding.